期刊文献+

119例脓毒症凝血、抗凝和纤溶功能的临床研究 被引量:1

A clinical study of sepsis-related coagulation disorder
分享 导出
摘要 目的探讨脓毒症患者凝血、抗凝、纤溶等各项实验室指标与SOFA评分、PCT质量浓度、7d存活率的相关性。方法 入组2017年2月至2018年3月武汉大学人民医院重症监护室119例脓毒症患者和外科择期手术119例非脓毒症患者。检测入院时活化部分凝血活酶时间(APTT)、PT国际标准化比值(PT-INR)、纤维蛋白原(FIB)、抗凝血酶Ⅲ活性(AT-Ⅲ)、D-二聚体(D-Dimer)、纤维蛋白原降解产物(FDP)、可溶性血栓调节蛋白(sTM)、凝血酶-抗凝血酶复合物(TAT)、纤溶酶-α2纤溶酶抑制物复合物(PIC)、组织型纤溶酶原激活剂及其抑制剂复合物(t-PAI-C)。采用Spearman相关性分析上述各项指标与SOFA评分、PCT质量浓度、7d存活率的相关性。结果①脓毒症患者入院时sTM、t-PAI-c、TAT与SOFA评分存在正相关;AT=Ⅲ、血小板计数与SOFA评分存在负相关;而PIC与SOFA评分不存在相关。②脓毒症患者人院时sTM、t-PAl—C与PCT存在正相关。血小板计数与PCT存在负相关,AT-Ⅲ、TAT、PIC与PCT不存在相关。③脓毒症患者入院时sTM、t-PAI-C、TAT与7d存活情况存在负相关;AT-Ⅲ、血小板计数与7d存活情况存在正相关;PIC与7d存活情况不存在相关。结论可溶性血栓调节蛋白(sTM)、凝血酶.抗凝血酶复合物(TAT)、血浆抗凝血酶Ⅲ(AT-Ⅲ)、组织型纤溶酶原激活剂及其抑制剂复合物(t-PAI-C),分别代表内皮细胞损伤,凝血功能高度激活,抗凝功能相对不足,纤维蛋白降解能力降低,是临床监测脓毒症凝血功能紊乱的良好指标,是包括PLT、1NR、APTT在内的脓毒症凝血功能障碍的核心诊断标准的有益补充。 Objective To study in the correlation of the laboratory markers of coagulation, fibrinolysis and thrombosis in patients with sepsis and SOFA score, the procalcitonin (PCT) concentration and seven-day survival rate. Methods From February 2017 to March 2018, 119 patients with sepsis admitted in ICU and another 119 patients with non-sepsis undergoing selective surgery were enrolled as control in this study. APTT (activated partial thromboplastin time), PT-INR (prothrombin time - international normalized ratio), FIB (fibrinogen), AT- Ⅲ(antithrombin Ⅲ ), D-Dimer, FDP (fibrinogen degradation products), sTM (soluble thrombomodulin), TAT (thrombin antithrombin complex), PIC (plasmin-a2 plasminogen inhibitor complex) and t-PAI-C (tissue plasminogen activator and its inhibitor complex), were simultaneously monitored at admission. The correlation between the given laboratory markers mentioned and SOFA score, the PCT concentration and seven-day survival rate were analyzed with the Spearman correlation analysis. Results ① In the patients with sepsis, a positive correlation between SOFA score and sTM, t-PAI-C, TAT respectively was found, and a negative correlation between SOFA score and PLT (platelet count) was observed, and no correlation between SOFA score and PIC was noticed. ② A positive correlation between PCT and sTM, t-PAI-C respectively was significant, a negative correlation between PCT and PLT was marked, and no correlation between PCT and AT- Ⅲ, TAT, PIC respectively was found. ③ A negative correlation between seven-day survival rate and sTM, t-PAI-C and TAT respectively was obvious, a positive correlation between seven-day survival rate and AT- Ⅲ, PLT respectively was occurred, and no correlation between seven-day survival rate and PIC was determined. Conclusions Soluble thrombomodulin (sTM), thrombin-antithrombin (TAT), antithrombin Ⅲ (AT- Ⅲ) and tissue plasminogen activator inhibitor complex (t-PAI-c) were good clinical monitoring indic
作者 魏捷 张东梅 吕菁君 刘艳红 姜洁 李嘉嫦 叶璐 李涛 万曦 Wei Jie, Zhang Dongmei, Lv Jingjun, Liu Yanhong, Jiang Jie, Li Jiachang, Ye Lu, Li Tao, Wan Xi(Department of Emergency Medicine, Renmin Hospital of Wuhan University(Wei J, Zhang DM, Lv JJ, Jiang J, Li JC, Ye L, Li T, Wan X), Department of Laboratory Medical Center, Renmin Hospital of Wuhan University(Liu YH). Wuhan, 430060 China)
出处 《中华急诊医学杂志》 CSCD 北大核心 2018年第8期905-911,共7页 Chinese Journal of Emergency Medicine
基金 国家自然科学基金(81372020)
关键词 脓毒症 凝血功能 预后 可溶性血栓调节蛋白 血浆抗凝血酶Ⅲ 凝血酶-抗 凝血酶复合物 Sepsis Coagulation Prognosis Soluble thrombomodulin Antithrombin Ⅲ Thrombin-antithrombin
作者简介 通信作者:魏捷,Email:weijie996@sina.com
  • 相关文献

参考文献6

二级参考文献28

  • 1侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:743
  • 2Lee CC, Chen SY, Tsai CL, et al. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department [ J ]. Shock, 2008, 29 (3) : 322-327. 被引量:1
  • 3Meisner M, Tschaikowsky K, Palmaers T, et al. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS [J]. Crit Care, 1999, 3 (1): 45-50. 被引量:1
  • 4Christofilopoulou S, Charvalos E, Petrikkos G. Could procalcitonin be a predictive biological marker in systemic fungal infections : study of 14 cases [J]. Eur J Intern Med, 2002, 13 (8) : 493- 495. 被引量:1
  • 5Han YY, Doughty LA, Kofos D, et al. Procalcitonin is persistently increased among children with poor outcome from bacterial sepsis[J].Pediatr Crit Care Med, 2003, 4 (1) : 21-25. 被引量:1
  • 6Hochreiter M, Ktihler T, Schweiger AM, et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial [ J]. Crit Care, 2009, 13 (3) : R83. 被引量:1
  • 7Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procaleitonin- based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the PmHOSP randomized controlled trial [J]. JAMA, 2009, 302 (10): 1059-1066. 被引量:1
  • 8Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States : analysis of incidence, outcome, and associated costs of care [J]. Crit Cm'e Med, 2001, 29 (7): 1303- 1310. 被引量:1
  • 9Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/ACCP/ATS/ SIS: 2001 SCCM/ ESICM/ ACCP/ A'IS/SIS International Sepsis Definitions Conference [ J]. Crit Care Med, 2003, 31 (4): 1250- 12.56. 被引量:1
  • 10Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosoeomial infections [J]. Am J Iniect Control, 1988, 16 (1) : 128- ldO. 被引量:1

共引文献85

同被引文献16

引证文献1

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈